(Q41187925)

28 September 2017

title

Cyclosporine A regulates T cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression (English)

1 reference

28 September 2017

1 reference

1 reference

Frishberg Y

1

1 reference

28 September 2017

Meyers CM

series ordinal

2

1 reference

28 September 2017

Kelly CJ

series ordinal

3

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

50

1 reference

28 September 2017

issue

1

1 reference

28 September 2017

page(s)

45-53

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1996.285

28 September 2017

exact match

0 references

cites work

The effects of cyclosporin A on the immune system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Treatment of severe lichen planus with cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In Vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Isolation and characterization of the nephritogenic antigen producing anti-tubular basement membrane disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

T cell recognition of epithelial self

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Expression of leucocyte and lymphocyte adhesion molecules in the human kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Effect of dexamethasone, 6-mercaptopurine and cyclosporine A on intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Direct interaction with primed CD4+ CD45R0+ memory T lymphocytes induces expression of endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 on the surface of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.285

7 January 2021

Identifiers

DOI

10.1038/KI.1996.285

1 reference

28 September 2017

1 reference